Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Avi Kapoor

FORGOTTEN HISTORY: Resmed analysts increase their forecasts after strong q2 earnings - The Untold Story

Two,Diverse,Crypto,Traders,Brokers,Stock,Exchange,Market,Investors,Discussing

Resmed Inc (NYSE:RMD) reported better-than-expected earnings for the second quarter on Thursday.

The company posted quarterly earnings of $2.55 per share which beat the analyst consensus estimate of $2.46 per share. The company reported quarterly sales of $1.348 billion which beat the analyst consensus estimate of $1.321 billion.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.